Jeffrey J. Raizer - Concepedia

Author

Jeffrey J. Raizer

Also Known As

Aparicio, Luis, Brain Tumor Trials Collaborative, J Raizer, J. J. Raizer, J. Raizer, J.J. Raizer, Jeffrey J Raizer, Jeffrey J. Raizer, Jeffrey Raizer, Jordan Raizer

353

Publications

13K

Citations

H-Index

Concepts

All Affiliations

Northwestern University Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Massachusetts General Hospital Dana-Farber Cancer Institute

About

Jeffrey J. Raizer is an author at Northwestern University specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	53	4.6K
2	Health Sciences	15	20	789
3	Social Sciences	2	2	83
4	Behavioral Sciences	2	2	83
5	Public Health	1	1	72

Jeffrey J. Raizer

105

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Michael Weller, Nicholas Butowski, David Tran, The Lancet Oncology Egfrviii-expressing GlioblastomaNeuro-oncologyAct IvGliomaInternational Phase 3	2017	1.1K
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma Junfei Zhao, Andrew Chen, Robyn D. Gartrell, Nature Medicine Neuro-oncologyTumor ImmunologyAnti-pd-1 ImmunotherapyCancer ImmunosurveillanceGlioma	2019	918
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality Roger Stupp, Eric T. Wong, Andrew A. Kanner, European Journal of Cancer	2012	828
Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Journal of Clinical Oncology	2013	476
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme David A. Reardon, Karen Fink, Tom Mikkelsen, Journal of Clinical Oncology	2008	470
Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08 Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn, Clinical Cancer Research	2006	426
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Investigational New Drugs Neuro-oncologyTumoral PathologyGliomaMedicineRecurrent Glioblastoma Multiforme	2005	400
Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma Gaurav Shah, Joachim Yahalom, Denise D. Correa, Journal of Clinical Oncology	2007	397
The Diagnosis and Treatment of Metastatic Spinal Tumor Mark H. Bilsky, Eric Lis, Jeffrey J. Raizer, The Oncologist	1999	263
A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases Lauren E. Abrey, Jon D. Olson, Jeffrey J. Raizer, Journal of Neuro-Oncology	2001	230

Page 1